Chen H Y, Yuan M, Livermore D M
Department of Medical Microbiology, London Hospital Medical College.
J Med Microbiol. 1995 Oct;43(4):300-9. doi: 10.1099/00222615-43-4-300.
Antimicrobial resistance among 1991 Pseudomonas aeruginosa isolates collected at 24 UK hospitals during late 1993 was surveyed. Three-hundred and seventy-two of the isolates were resistant, or had reduced susceptibility, to some or all of azlocillin, carbenicillin, ceftazidime, imipenem and meropenem, and the mechanisms underlying their behaviour were examined. Only 13 isolates produced secondary beta-lactamases: six possessed PSE-1 or PSE-4 enzymes and seven had novel OXA enzyme types. Those with PSE types were highly resistant to azlocillin and carbenicillin whereas those with OXA enzymes were less resistant to these penicillins. Chromosomal beta-lactamase derepression was demonstrated in 54 isolates, most of which were resistant to ceftazidime and azlocillin although susceptible to carbenicillin and carbapenems. beta-Lactamase-independent "intrinsic" resistance occurred in 277 isolates and is believed to reflect some combination of impermeability and efflux. Two forms were seen: the classical type, present in 195 isolates, gave carbenicillin resistance (MIC > 128 mg/L) and reduced susceptibility to ciprofloxacin and to all beta-lactam agents except imipenem; a novel variant, seen in 82 isolates, affected only azlocillin, ceftazidime and, to a small extent, meropenem. Resistance to imipenem was largely dissociated from that to other beta-lactam agents, and probably reflected loss of D2 porin, whereas resistance to meropenem was mostly associated with intrinsic resistance to penicillins and cephalosporins. Comparison of the present results with those of a similar study in 1982 revealed significant increases in the proportions of isolates with intrinsic resistance or stable derepression (p < 0.01, chi 2 test).(ABSTRACT TRUNCATED AT 250 WORDS)
对1993年末在英国24家医院收集的1991株铜绿假单胞菌分离株的抗菌药物耐药性进行了调查。其中372株分离株对阿洛西林、羧苄西林、头孢他啶、亚胺培南和美罗培南中的部分或全部耐药或敏感性降低,并对其耐药机制进行了研究。只有13株分离株产生了继发性β-内酰胺酶:6株具有PSE-1或PSE-4酶,7株具有新型OXA酶类型。具有PSE类型的菌株对阿洛西林和羧苄西林高度耐药,而具有OXA酶的菌株对这些青霉素的耐药性较低。在54株分离株中证实了染色体β-内酰胺酶去阻遏,其中大多数对头孢他啶和阿洛西林耐药,但对羧苄西林和碳青霉烯类敏感。277株分离株出现了不依赖β-内酰胺酶的“固有”耐药性,据信这反映了通透性和外排的某种组合。观察到两种形式:经典类型存在于195株分离株中,导致对羧苄西林耐药(MIC>128mg/L),并降低了对环丙沙星和除亚胺培南外的所有β-内酰胺类药物的敏感性;一种新型变体存在于82株分离株中,仅影响阿洛西林、头孢他啶,并在一定程度上影响美罗培南。对亚胺培南的耐药性与对其他β-内酰胺类药物的耐药性基本无关,可能反映了D2孔蛋白的缺失,而对美罗培南的耐药性主要与对青霉素和头孢菌素的固有耐药性有关。将目前的结果与1982年一项类似研究的结果进行比较,发现具有固有耐药性或稳定去阻遏的分离株比例显著增加(p<0.01,卡方检验)。(摘要截短于250字)